Recent INKT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:05:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 06:27:56 PM
- MiNK Therapeutics Announces Virtual Annual Shareholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:30:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/22/2024 08:33:15 PM
- MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:02:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:30:18 AM
- MiNK Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 11:28:28 AM
- MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- MiNK to Provide Corporate Update and First Quarter 2024 Financial Report • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR • GlobeNewswire Inc. • 04/08/2024 04:00:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- MiNK Reports Fourth Quarter and Year-End 2023 Results • GlobeNewswire Inc. • 03/21/2024 11:00:00 AM
- MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report • GlobeNewswire Inc. • 03/07/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:00:11 PM
- First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab • GlobeNewswire Inc. • 02/14/2024 01:00:00 PM
- MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 01:00:08 AM
- ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development • GlobeNewswire Inc. • 12/20/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 11:05:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:00:23 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM